Login / Signup

Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens.

David W MorgensMichael WainbergEvan August BoyleOana UrsuCarlos L ArayaC Kimberly TsuiMichael S HaneyGaelen T HessKyuho HanEdwin E JengAmy LiMichael P SnyderWilliam J GreenleafAnshul KundajeMichael C Bassik
Published in: Nature communications (2017)
CRISPR-Cas9 screens are powerful tools for high-throughput interrogation of genome function, but can be confounded by nuclease-induced toxicity at both on- and off-target sites, likely due to DNA damage. Here, to test potential solutions to this issue, we design and analyse a CRISPR-Cas9 library with 10 variable-length guides per gene and thousands of negative controls targeting non-functional, non-genic regions (termed safe-targeting guides), in addition to non-targeting controls. We find this library has excellent performance in identifying genes affecting growth and sensitivity to the ricin toxin. The safe-targeting guides allow for proper control of toxicity from on-target DNA damage. Using this toxicity as a proxy to measure off-target cutting, we demonstrate with tens of thousands of guides both the nucleotide position-dependent sensitivity to single mismatches and the reduction of off-target cutting using truncated guides. Our results demonstrate a simple strategy for high-throughput evaluation of target specificity and nuclease toxicity in Cas9 screens.
Keyphrases
  • high throughput
  • crispr cas
  • dna damage
  • genome editing
  • genome wide
  • oxidative stress
  • single cell
  • cancer therapy
  • escherichia coli
  • dna repair
  • drug delivery
  • oxide nanoparticles
  • high glucose
  • copy number